An overview of vaccine adjuvants: current evidence and future perspectives

A Facciolà, G Visalli, A Laganà, A Di Pietro - Vaccines, 2022 - mdpi.com
Vaccinations are one of the most important preventive tools against infectious diseases.
Over time, many different types of vaccines have been developed concerning the antigen …

Effect of vaccine administration modality on immunogenicity and efficacy

L Zhang, W Wang, S Wang - Expert review of vaccines, 2015 - Taylor & Francis
The many factors impacting the efficacy of a vaccine can be broadly divided into three
categories: features of the vaccine itself, including immunogen design, vaccine type …

Anti–PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM

D Mathios, JE Kim, A Mangraviti, J Phallen… - Science translational …, 2016 - science.org
The immunosuppressive effects of chemotherapy present a challenge for designing effective
cancer immunotherapy strategies. We hypothesized that although systemic chemotherapy …

A systematic review on poly (I: C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy

J De Waele, T Verhezen, S van der Heijden… - Journal of Experimental …, 2021 - Springer
Immunotherapy is currently under intensive investigation as a potential breakthrough
treatment option for glioblastoma. Given the anatomical and immunological complexities …

Vaccine adjuvant uses of poly-IC and derivatives

KAO Martins, S Bavari, AM Salazar - Expert review of vaccines, 2015 - Taylor & Francis
Pathogen-associated molecular patterns (PAMPs) are stand-alone immunomodulators or
'danger signals,'that are increasingly recognized as critical components of many modern …

Exploration of pattern recognition receptor agonists as candidate adjuvants

GH Ong, BSX Lian, T Kawasaki… - Frontiers in cellular and …, 2021 - frontiersin.org
Adjuvants are used to maximize the potency of vaccines by enhancing immune reactions.
Components of adjuvants include pathogen-associated molecular patterns (PAMPs) and …

Immunotherapy advances for glioblastoma

DA Reardon, G Freeman, C Wu, EA Chiocca… - Neuro …, 2014 - academic.oup.com
Survival for patients with glioblastoma, the most common high-grade primary CNS tumor,
remains poor despite multiple therapeutic interventions including intensifying cytotoxic …

Therapeutic immune modulation against solid cancers with intratumoral poly-ICLC: a pilot trial

C Kyi, V Roudko, R Sabado, Y Saenger, W Loging… - Clinical Cancer …, 2018 - AACR
Purpose: Polyinosinic-polycytidylic acid-poly-l-lysine carboxymethylcellulose (poly-ICLC), a
synthetic double-stranded RNA complex, is a ligand for toll-like receptor-3 and MDA-5 that …

Long-acting vaccine delivery systems

P Walvekar, P Kumar, YE Choonara - Advanced Drug Delivery Reviews, 2023 - Elsevier
Bolus vaccines are often administered multiple times due to rapid clearance and reduced
transportation to draining lymph nodes resulting in inadequate activation of T and B …

[HTML][HTML] A phase II study of Tg4010 (Mva-Muc1-Il2) in association with chemotherapy in patients with stage III/IV Non-small cell lung cancer

R Ramlau, E Quoix, J Rolski, M Pless, H Lena… - Journal of Thoracic …, 2008 - Elsevier
Background TG4010 is a recombinant viral vector expressing both the tumor-associated
antigen MUC1 and Interleukine-2. This vector is based on the modified virus of Ankara, a …